Deciphera Pharmaceuticals Stock Price - DCPH

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Deciphera Pharmaceuticals Inc DCPH NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 34.02 0.00 0.00 0.00 34.02 04:00:00
Bid Price Ask Price Spread Spread % News
15.00 44.55 29.55 66.33% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Deciphera Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.72B 50.65M $ -99.85M -2.83 - 50.55M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Deciphera Pharmaceuticals News

Date Time Source News Article
10/16/201916:34Business WireDeciphera Pharmaceuticals to Present Data Updates From..
10/08/201916:22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
10/02/201907:00Business WireDeciphera Pharmaceuticals Appoints Matthew L. Sherman, M.D...
9/30/201909:21Edgar (US Regulatory)Current Report Filing (8-k)
9/30/201909:06Business WireDeciphera Pharmaceuticals Announces Late-Breaking Oral..
9/25/201907:00Business WireDeciphera Pharmaceuticals, Inc. to Present at the 2019..
9/23/201916:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)

Latest DCPH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DCPH Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week31.7635.0831.7633.0905272k2.267.12%
1 Month36.0737.2731.3734.2597393k-2.05-5.68%
3 Months21.8347.899919.8834.6935794k12.1955.84%
6 Months23.5647.899919.8832.0915490k10.4644.40%
1 Year28.6247.899918.5529.3258373k5.418.87%
3 Years20.0547.899915.1528.9252293k13.9769.68%
5 Years20.0547.899915.1528.9252293k13.9769.68%

Deciphera Pharmaceuticals Description

Deciphera Pharmaceuticals Inc is a biotechnology company, develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib.
Your Recent History
NASDAQ
DCPH
Deciphera ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191017 10:13:48